Skip to main content

Effects of four single nucleotide polymorphisms in microRNA-coding genes on lung cancer risk

Tumor Biology volume 35, pages 10815–10824 (2014)Cite this article

Abstract

No clear consensus has been reached on the four single nucleotide polymorphisms (miR-196a2 gene rs11614913, miR-146a gene rs2910164, miR-149 gene rs2292832, and miR-499 gene rs3746444) in microRNA-coding genes and lung cancer risk. We performed a meta-analysis in an effort to systematically explore the possible association. A computer retrieval of PubMed, Embase, and Institute for Scientific Information (ISI) Web of Science electronic databases was conducted prior to May 2014. References of retrieved articles were also screened. The fixed effects model and the random effects model were applied for dichotomous outcomes to combine the results of the individual studies. Seven studies including 3,705 cases and 4,099 controls were finally included according to the inclusion criteria. Statistical association could be found between rs11614913 polymorphism and lung cancer [C vs. T: P = 0.01, odds ratio (OR) = 1.11, 95 % confidence interval (CI) 1.03–1.20, P heterogeneity = 0.22, fixed effects model; CC + CT vs. TT: P = 0.01, OR = 1.18, 95 % CI 1.04–1.34, P heterogeneity = 0.32, fixed effects model; CC vs. TT: P = 0.009, OR = 1.24, 95 % CI 1.06–1.45, P heterogeneity = 0.34, fixed effects model]. Subgroup analysis found this association in the East Asians. As for rs2910164 polymorphism and lung cancer risk, significant association could be found in allele comparison (G vs. C: P = 0.03, OR = 0.92, 95 % CI 0.85–0.99, P heterogeneity = 0.15, fixed effects model) and in the dominant genetic model (GG + CG vs. CC: P = 0.03, OR = 0.86, 95 % CI 0.76–0.99, P heterogeneity = 0.31, fixed effects model). In the East Asian subgroup, association could also be found. No association was observed on rs2292832 or rs3746444 polymorphism and lung cancer. Our study suggested that the miR-196a2 gene rs11614913 polymorphism and the miR-146a gene rs2910164 polymorphism might associate with lung cancer risk.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.

    PubMed  Article  Google Scholar 

  2. Alberg AJ, Brock MV, Samet JM. Epidemiology of lung cancer: looking to the future. J Clin Oncol. 2005;23:3175–85.

    PubMed  Article  Google Scholar 

  3. National Comprehensive Cancer Network (NCCN) Non-small cell lung cancer USA. NCCN clinical practice guidelines in oncology: non-small cell lung cancer V.4.2014.

  4. National Comprehensive Cancer Network (NCCN) Small cell lung cancer USA. NCCN clinical practice guidelines in oncology: small cell lung cancer V.2.2014.

  5. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294:853–8.

    CAS  PubMed  Article  Google Scholar 

  6. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell. 2003;113:673–6.

    CAS  PubMed  Article  Google Scholar 

  7. Xu P, Guo M, Hay BA. MicroRNAs and the regulation of cell death. Trends Genet. 2004;20:617–24.

    CAS  PubMed  Article  Google Scholar 

  8. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–8.

    CAS  PubMed  Article  Google Scholar 

  9. Esquela-Kerscher A, Slack FJ. Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–69.

    CAS  PubMed  Article  Google Scholar 

  10. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007;39:673–7.

    CAS  PubMed  Article  Google Scholar 

  11. Vannini I, Fanini F, Fabbri M. MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis. Clin Biochem. 2013;46:918–25.

    CAS  PubMed  Article  Google Scholar 

  12. Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L, et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest. 2008;118:2600–8.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  13. Garcia AI, Buisson M, Bertrand P, Rimokh R, Rouleau E, Lopez BS, et al. Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. EMBO Mol Med. 2011;3:279–90.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  14. Li Y, Vandenboom 2nd TG, Wang Z, Kong D, Ali S, Philip PA, et al. miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res. 2010;70:1486–95.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  15. Jin L, Hu WL, Jiang CC, Wang JX, Han CC, Chu P, et al. MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proc Natl Acad Sci U S A. 2011;108:15840–5.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  16. Wang Y, Zheng X, Zhang Z, Zhou J, Zhao G, Yang J, et al. MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer. PLoS One. 2012;7:e41693.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  17. Liu X, Zhang Z, Sun L, Chai N, Tang S, Jin J, et al. MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4. Carcinogenesis. 2011;32:1798–805.

    CAS  PubMed  Article  Google Scholar 

  18. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol. 2010;28:1721–6.

    PubMed  Article  Google Scholar 

  19. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955;19:251–3.

    CAS  PubMed  Article  Google Scholar 

  20. Niu W, Qi Y, Gao P, Zhu D. Association of TGFB1–509 C>T polymorphism with breast cancer: evidence from a meta-analysis involving 23,579 subjects. Breast Cancer Res Treat. 2010;124:243–9.

    CAS  PubMed  Article  Google Scholar 

  21. Lou Y, Li R, Zhang Y, Zhong R, Pei J, Xiong L, et al. XPA gene rs1800975 single nucleotide polymorphism and lung cancer risk: a meta-analysis. Tumour Biol. 2014;35:6607–17.

  22. Guedj M, Nuel G, Prum B. A note on allelic tests in case-control association studies. Ann Hum Genet. 2008;72:407–9.

    CAS  PubMed  Article  Google Scholar 

  23. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820–6.

    CAS  PubMed  Article  Google Scholar 

  24. Petitti D. Meta-analysis, decision analysis, and cost-effectiveness analysis. New York: Oxford University Press; 1994. p. 15–20.

    Google Scholar 

  25. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  26. Wu Z, Lou Y, Jin W, Liu Y, Lu L, Chen Q, et al. The Connexin37 gene C1019T polymorphism and risk of coronary artery disease: a meta-analysis. Arch Med Res. 2014;45:21–30.

    CAS  PubMed  Article  Google Scholar 

  27. Zhang MY, Chen FY, Zhong H. Meta-analysis of human leukocyte antigen genetic polymorphisms and susceptibility to chronic myelogenous leukemia in Chinese population. Leuk Res. 2011;35:1564–70.

    CAS  PubMed  Article  Google Scholar 

  28. Tian T, Shu Y, Chen J, Hu Z, Xu L, Jin G, et al. A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev. 2009;18:1183–7.

    CAS  PubMed  Article  Google Scholar 

  29. Kim MJ, Yoo SS, Choi YY, Park JY. A functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean population. Lung Cancer. 2010;69:127–9.

    PubMed  Article  Google Scholar 

  30. Hong YS, Kang HJ, Kwak JY, Park BL, You CH, Kim YM, et al. Association between microRNA196a2 rs11614913 genotypes and the risk of non-small cell lung cancer in Korean population. J Prev Med Public Health. 2011;44:125–30.

    PubMed Central  PubMed  Article  Google Scholar 

  31. Zhang MW, Yu YX, Jin MJ, Pan YF, Jiang X, Li QL, et al. Association of miR-605 and miR-149 genetic polymorphisms with related risk factors of lung cancer susceptibility. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2011;40:265–71 (in Chinese).

    CAS  PubMed  Google Scholar 

  32. Vinci S, Gelmini S, Pratesi N, Conti S, Malentacchi F, Simi L, et al. Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med. 2011;49:2073–80.

    CAS  PubMed  Article  Google Scholar 

  33. Jeon HS, Lee YH, Lee SY, Jang JA, Choi YY, Yoo SS, et al. A common polymorphism in pre-microRNA-146a is associated with lung cancer risk in a Korean population. Gene. 2014;534:66–71.

    CAS  PubMed  Article  Google Scholar 

  34. Parlayan C, Ikeda S, Sato N, Sawabe M, Muramatsu M, Arai T. Association analysis of single nucleotide polymorphisms in miR-146a and miR-196a2 on the prevalence of cancer in elderly Japanese: a case-control study. Asian Pac J Cancer Prev. 2014;15:2101–7.

    PubMed  Article  Google Scholar 

  35. Ling XX, Li YY, Yang L, Ji WD, Bin XN, LV JC. Genetic variant in seed region of has-miR-499-3p (rs3746444A>G) increases risk of lung cancer. Chin J Public Health. 2011; 27: 1105–7 (in Chinese).

  36. Wang G, Wang W, Gao W, Lv J, Fang J. Two functional polymorphisms in microRNAs and lung cancer risk: a meta-analysis. Tumour Biol. 2014;35:2693–9.

    CAS  PubMed  Article  Google Scholar 

  37. Calvo R, West J, Franklin W, Erickson P, Bemis L, Li E, et al. Altered HOX and WNT7A expression in human lung cancer. Proc Natl Acad Sci U S A. 2000;97:12776–81.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  38. Miller GJ, Miller HL, van Bokhoven A, Lambert JR, Werahera PN, Schirripa O, et al. Aberrant HOXC expression accompanies the malignant phenotype in human prostate. Cancer Res. 2003;63:5879–88.

    CAS  PubMed  Google Scholar 

  39. Ying J, Srivastava G, Hsieh WS, Gao Z, Murray P, Liao SK, et al. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin Cancer Res. 2005;11:6442–9.

    CAS  PubMed  Article  Google Scholar 

  40. Shen J, Ambrosone CB, DiCioccio RA, Odunsi K, Lele SB, Zhao H. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis. 2008;29:1963–6.

    CAS  PubMed  Article  Google Scholar 

  41. Hung PS, Chang KW, Kao SY, Chu TH, Liu CJ, Lin SC. Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression. Oral Oncol. 2012;48:404–8.

    CAS  PubMed  Article  Google Scholar 

Download references

Conflicts of interest

None

Author information

Affiliations

  1. Department of Pulmonary, Shanghai Chest Hospital, Shanghai Jiaotong University, 241 West Huaihai Road, Shanghai, 200030, People’s Republic of China

    Xiaohong Fan

  2. Department of Cardiology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People’s Republic of China

    Zhijun Wu

Authors
  1. Xiaohong Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhijun Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiaohong Fan.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fan, X., Wu, Z. Effects of four single nucleotide polymorphisms in microRNA-coding genes on lung cancer risk. Tumor Biol. 35, 10815–10824 (2014). https://doi.org/10.1007/s13277-014-2371-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2371-5

Keywords

  • Lung cancer
  • Single nucleotide polymorphism
  • MicroRNA
  • Meta-analysis